• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share

All Testimony

All testimony prior to 2017 is archived. View and search the archive.

2020 | 2019 | 2018 | 2017

All | Mar | Apr | May | Jun | Jul | Sep | Oct | Nov

November

Encouraging Healthy Communities: Perspective from the Surgeon General
November 15, 2017 | By: Vice Admiral Jerome M. Adams, M.D., M.P.H.
S. 465 “Independent Outside Audit of the Indian Health Service Act of 2017”
November 8, 2017 | By: Elizabeth A. Fowler

October

Oversight of the United States Refugee Admissions Program
October 26, 2017 | By: Scott Lloyd
Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives
October 25, 2017 | By: Elinore McCance-Katz, M.D., Ph.D., Anne Schuchat, M.D., Nora Volkow, M.D., and Scott Gottlieb, M.D.
Hurricane Response
October 24, 2017 | By: Robert Kadlec, M.D.
2017 Hurricane Response
October 24, 2017 | By: RADM Stephen C. Redd, M.D.
Examining HHS’s Public Health Preparedness for and Response to the 2017 Hurricane Season
October 24, 2017 | By: Kimberly Brandt
Examining HHS’s Public Health Preparedness for and Response to the 2017 Hurricane Season
October 24, 2017 | By: Scott Gottlieb, M.D.
The Federal Response to the Opioid Crisis
October 5, 2017 | By: Elinore McCance-Katz, M.D., Ph.D., Deborah Houry, M.D., MPH, Francis Collins, M.D., Ph.D., and Scott Gottlieb, M.D.
Examining Patient Access to Investigational Drugs
October 3, 2017 | By: Scott Gottlieb, M.D.

September

Modernizing FDA’s Regulation of Over-The-Counter Drugs
September 13, 2017 | By: Janet Woodcock, M.D.
High Risk Indian Programs: Progress and Efforts in Addressing GAO’s Recommendations
September 13, 2017 | By: RADM Michael D. Weahkee, M.B.A., MHSA

July

Antitrust Concerns and the FDA Approval Process
July 27, 2017 | By: Scott Gottlieb, M.D.
Progress Toward A Cure for Type I Diabetes: Research and the Artificial Pancreas
July 26, 2017 | By: Griffin P. Rodgers, M.D., M.A.C.P.

June

The MS-13 Problem: Investigating Gang Membership, its Nexus to Illegal Immigration, and Federal Efforts to End the Threat
June 21, 2017 | By: Scott Lloyd
Restoring Accountability in the Indian Health Service Act of 2017
June 21, 2017 | By: RADM Chris Buchanan, R.E.H.S., M.P.H.
The President’s Fiscal Year 2018 Budget
June 15, 2017 | By: Dr. Thomas Price
The Federal Information Technology Acquisition Reform (FITARA) Scoreboard 4.0
June 13, 2017 | By: Beth Anne B. Killoran
“Legislative Hearing”
June 13, 2017 | By: RADM Chris Buchanan, R.E.H.S., M.P.H.
Examining the Role of the Department of Health and Human Services in Health Care Cybersecurity
June 8, 2017 | By: Emery Csulak, Steven Curren, and Leo Scanlon
The President’s Fiscal Year 2018 Budget
June 8, 2017 | By: Dr. Thomas Price
The President’s Fiscal Year 2018 Budget
June 8, 2017 | By: Dr. Thomas Price
H.R. 1901, A Bill to Provide for the Conveyance of Certain Property to the Southeast Alaska Regional Health Consortium Located in Sitka, Alaska
June 7, 2017 | By: RADM Chris Buchanan

May

U.S. Public Health Response to the Zika Virus: Continuing Challenges
May 23, 2017 | By: Lyle Petersen, M.D.
Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease
May 23, 2017 | By: Anthony S. Fauci, M.D.
High Risk, No Reward: GAO’s High Risk List for Indian Programs
May 17, 2017 | By: RADM Chris Buchanan, R.E.H.S., M.P.H.
S.825, A Bill to Provide for the Conveyance of Certain Property to the Southeast Alaska Regional Health Consortium Located in Sitka, Alaska
May 10, 2017 | By: RADM Chris Buchanan, R.E.H.S., M.P.H.
Examining Improvements to the Regulation of Medical Technologies
May 2, 2017 | By: Jeffrey Shuren, M.D., J.D.
Combating Waste, Fraud, and Abuse in Medicaid’s Personal Care Services Program
May 2, 2017 | By: Tim Hill

April

Native American Children’s Safety Act
April 21, 2017 | By: Nikki Hatch

March

Diabetes Prevention Native Youth
March 29, 2017 | By: RADM Chris Buchanan, R.E.H.S., M.P.H.
The President’s Fiscal Year 2018 Budget Blueprint
March 29, 2017 | By: Dr. Thomas Price
Examining FDA’s Medical Device User Fee Program
March 28, 2017 | By: Jeffrey Shuren, M.D., J.D.
Examining FDA’s Prescription Drug User Fee Program
March 22, 2017 | By: Janet Woodcock
Prescription Drug User Fee Act Reauthorization (PDUFA VI), Medical Device User Fee Act Reauthorization (MDUFA IV), Generic Drug User Fee Act Reauthorization (GDUFA II), Biosimilar User Fee Act Reauthorization (BsUFA II) before Committee on Health, Education, Labor and Pensions
March 21, 2017 | By: the Directors of CDER, CBER, and CDAH
Research on the Use and Misuse of Fentanyl and Other Synthetic Opioids
March 21, 2017 | By: Wilson M. Compton, M.D.
Fentanyl: The Next Wave of the Opioid Crisis
March 21, 2017 | By: Debra Houry, M.D.
Generic Drug User Fee Act Reauthorization (GDUFA II) and Biosimilar User Fee Act Reauthorization (BsUFA II)
March 2, 2017 | By: Janet Woodcock
Generic Drug User Fee Act Reauthorization (GDUFA II) Biosimilar User Fee Act Reauthorization (BsUFA II)
March 2, 2017 | By: Janet Woodcock